These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27004468)

  • 1. Effects of (+)-usnic acid and (+)-usnic acid-liposome on Toxoplasma gondii.
    Si K; Wei L; Yu X; Wu F; Li X; Li C; Cheng Y
    Exp Parasitol; 2016 Jul; 166():68-74. PubMed ID: 27004468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on (+)-usnic acid: A new application to treat toxoplasmosis.
    Si K; Wei L; Yu X; Wu F; Li X; Li C; Cheng Y
    Data Brief; 2016 Sep; 8():648-53. PubMed ID: 27437438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
    Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-
    Guo HY; Jin C; Zhang HM; Jin CM; Shen QK; Quan ZS
    J Agric Food Chem; 2019 Aug; 67(34):9630-9642. PubMed ID: 31365255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
    Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
    Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
    Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
    Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The study on skin wound healing promoting action of sodium usnic acid].
    Jin J; Dong Y; He L
    Zhong Yao Cai; 2005 Feb; 28(2):109-11. PubMed ID: 15981883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro.
    da Silva LL; Portes Jde A; de Araújo MH; Silva JL; Rennó MN; Netto CD; da Silva AJ; Costa PR; De Souza W; Seabra SH; DaMatta RA
    Parasitol Int; 2015 Dec; 64(6):622-31. PubMed ID: 26335616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo.
    Zhang X; Jin L; Cui Z; Zhang C; Wu X; Park H; Quan H; Jin C
    Exp Parasitol; 2016 Jun; 165():95-102. PubMed ID: 26993085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of diclazuril against Toxoplasma gondii in cultured cells and mice.
    Lindsay DS; Blagburn BL
    Am J Vet Res; 1994 Apr; 55(4):530-3. PubMed ID: 8017699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New life for an old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain.
    Zhang JL; Si HF; Shang XF; Zhang XK; Li B; Zhou XZ; Zhang JY
    Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():27-34. PubMed ID: 30599391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I.
    Tang Y; Hou S; Li X; Wu M; Ma B; Wang Z; Jiang J; Deng M; Duan Z; Tang X; Liu Y; Wang W; Han X; Jiang L
    Exp Parasitol; 2019 Mar; 198():17-25. PubMed ID: 30682337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of artesunate on Toxoplasma gondii: in vitro and in vivo studies.
    El Zawawy LA
    J Egypt Soc Parasitol; 2008 Apr; 38(1):185-201. PubMed ID: 19143130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could miltefosine be used as a therapy for toxoplasmosis?
    Eissa MM; Barakat AM; Amer EI; Younis LK
    Exp Parasitol; 2015 Oct; 157():12-22. PubMed ID: 26112396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii.
    Tomavo S; Boothroyd JC
    Int J Parasitol; 1995 Nov; 25(11):1293-9. PubMed ID: 8635881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiolactomycin analogues as potential anti-Toxoplasma gondii agents.
    Martins-Duarte ES; Jones SM; Gilbert IH; Atella GC; de Souza W; Vommaro RC
    Parasitol Int; 2009 Dec; 58(4):411-5. PubMed ID: 19698800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF; Gomes AO; Ferro EA; Napolitano DR; Mineo JR; Silva NM
    Vet Parasitol; 2012 Jun; 187(1-2):44-52. PubMed ID: 22281151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis.
    El-Zawawy LA; El-Said D; Mossallam SF; Ramadan HS; Younis SS
    Exp Parasitol; 2015 Feb; 149():54-64. PubMed ID: 25499511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: in vitro and in vivo activities of the hydroxynaphthoquinone 2-hydroxy-3-(1'-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine.
    Ferreira RA; Oliveira AB; Ribeiro MF; Tafuri WL; Vitor RW
    Exp Parasitol; 2006 Jun; 113(2):125-9. PubMed ID: 16458300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.